Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
178.50
+2.71 (1.54%)
Sep 11, 2025, 4:00 PM EDT - Market closed
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 31, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
$656,242
Profits / Employee
$164,091
Market Cap
429.89B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138,100 | 6,200 | 4.70% |
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Dec 31, 2022 | 152,700 | 11,000 | 7.76% |
Dec 31, 2021 | 141,700 | 7,200 | 5.35% |
Dec 31, 2020 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | 132,200 | -2,900 | -2.15% |
Dec 30, 2018 | 135,100 | 1,100 | 0.82% |
Dec 31, 2017 | 134,000 | 7,600 | 6.01% |
Dec 31, 2016 | 126,400 | -700 | -0.55% |
Dec 31, 2015 | 127,100 | 600 | 0.47% |
Dec 28, 2014 | 126,500 | -1,600 | -1.25% |
Dec 29, 2013 | 128,100 | 500 | 0.39% |
Dec 30, 2012 | 127,600 | 9,700 | 8.23% |
Dec 31, 2011 | 117,900 | 3,900 | 3.42% |
Dec 31, 2010 | 114,000 | -1,500 | -1.30% |
Dec 31, 2009 | 115,500 | -3,200 | -2.70% |
Dec 28, 2008 | 118,700 | -500 | -0.42% |
Dec 30, 2007 | 119,200 | -3,000 | -2.45% |
Dec 31, 2006 | 122,200 | 6,600 | 5.71% |
Dec 31, 2005 | 115,600 | 5,600 | 5.09% |
Dec 31, 2004 | 110,000 | -1,000 | -0.90% |
Dec 28, 2003 | 111,000 | 3,000 | 2.78% |
Dec 29, 2002 | 108,000 | 6,000 | 5.88% |
Dec 30, 2001 | 102,000 | 1,000 | 0.99% |
Dec 31, 2000 | 101,000 | 3,200 | 3.27% |
Dec 31, 1999 | 97,800 | 4,700 | 5.05% |
Dec 31, 1998 | 93,100 | 2,600 | 2.87% |
Dec 28, 1997 | 90,500 | 1,200 | 1.34% |
Dec 29, 1996 | 89,300 | 7,000 | 8.51% |
Dec 31, 1995 | 82,300 | 800 | 0.98% |
Dec 31, 1994 | 81,500 | -100 | -0.12% |
Dec 31, 1993 | 81,600 | -3,300 | -3.89% |
Dec 31, 1992 | 84,900 | 2,200 | 2.66% |
Dec 31, 1991 | 82,700 | 500 | 0.61% |
Dec 31, 1990 | 82,200 | -900 | -1.08% |
Dec 31, 1989 | 83,100 | 1,800 | 2.21% |
Dec 31, 1988 | 81,300 | 3,100 | 3.96% |
Dec 31, 1987 | 78,200 | 1,100 | 1.43% |
Dec 31, 1986 | 77,100 | 2,200 | 2.94% |
Dec 31, 1985 | 74,900 | 700 | 0.94% |
Dec 31, 1984 | 74,200 | -3,200 | -4.13% |
Dec 31, 1983 | 77,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
JNJ News
- 22 hours ago - Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm - GlobeNewsWire
- 1 day ago - Johnson & Johnson (JNJ) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 1 day ago - Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales. - Barrons
- 2 days ago - US FDA approves J&J's bladder cancer treatment - Reuters
- 2 days ago - U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated - PRNewsWire
- 2 days ago - Johnson & Johnson: JNJ Stock To $250? - Forbes
- 3 days ago - Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors - Business Wire
- 3 days ago - Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum - Business Wire